Table 2. ADI-Panels accurately recognize APL patients from AML patients in our multi-centers study.
ADI-Panel | MICM | Total | |
---|---|---|---|
APL | Non-APL | ||
APL | 200 | 5 | 205 |
Non-APL | 2 | 627 | 629 |
Total | 202 | 632 | 834 |
Note: ADI-Panels, APL diagnostic immunophenotypic panel; MICM, morphology, immunology, cytology, and molecular biology; Data comparisons were performed using McNemar (P = 0.453) and Kappa tests (Kappa = 0.977, P < 0.001).